G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2011
11/17/2011	US20110282591 Pipeline inspection apparatus and method using radio frequency identification and inertial navigation
11/17/2011	US20110282588 Method to automatically identify peaks and monoisotopic peaks in mass spectral data for biomolecular applications
11/17/2011	US20110282585 Hepatic disease-evaluating apparatus, hepatic disease-evaluating method, hepatic disease-evaluating system, hepatic disease-evaluating program and recording medium
11/17/2011	US20110282174 Analysis device with user-friendly menu controls
11/17/2011	US20110282066 Screening method for substance useful as agent for treating prostate cancer
11/17/2011	US20110281939 Polynucleotide aptamer-based cross-linked materials and uses thereof
11/17/2011	US20110281880 Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring
11/17/2011	US20110281802 Composition for treatment and prevention of hair loss and premature graying of hair
11/17/2011	US20110281801 Prediction and prevention of preeclampsia
11/17/2011	US20110281792 Binding-site modified lectins and uses thereof
11/17/2011	US20110281789 Ulbp antibodies
11/17/2011	US20110281760 Supports for assaying analytes and methods of making and using thereof
11/17/2011	US20110281758 Methods of diagnosing and predicting renal disease
11/17/2011	US20110281757 Methods and Compositions for Detection of Complement Fixing Antibodies
11/17/2011	US20110281754 Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids
11/17/2011	US20110281753 Rationale, methods, and assays for identifying human and non-human primate taste specific genes and use thereof in taste modulator and therapeutic screening assays
11/17/2011	US20110281752 Beta-secretase enzyme compositions and methods
11/17/2011	US20110281749 Human t2r receptors for acetaminophen, ranitidine, strychnine and denatonium and related assays for identifying human bitter taste modulators
11/17/2011	US20110281747 Biomarkers for predicting rapid response to hcv treatment
11/17/2011	US20110281743 Systems and methods for isolating cells in cell colonies in culture
11/17/2011	US20110281374 Biomarker
11/17/2011	US20110281369 Analysis of mycophenolic acid in saliva using liquid chromatography tandem mass spectrometry
11/17/2011	US20110281368 Nanoparticle derivatization of targets for detecting and determining the concentrations of targets by impeadance-spectroscopy-based sensors
11/17/2011	US20110281367 Device and method for detection of harmful substances
11/17/2011	US20110281366 Systems and Methods of Detecting and Demonstrating Hair Damage Via Detection of Protein Loss
11/17/2011	US20110281365 Protein-based assays for screening of the ige-receptor interaction
11/17/2011	US20110281364 Method and marker for diagnosing diabetes mellitus
11/17/2011	US20110281344 Detection Device
11/17/2011	US20110281330 Minicells expressing antibodies or derivatives thereof and comprising biologically active compounds
11/17/2011	US20110281297 Tissue Processing Device with Ultrasonic Measuring Chamber
11/17/2011	US20110281293 Preparation and its use of derivatization reagent for detecting l-carnitine or d-carnitine
11/17/2011	US20110281291 Identification and/or characterization of a microbial agent using taxonomic hierarchical classification
11/17/2011	US20110281288 Reusable Nanowire Field Effect Transistor System for Detecting Biomolecular Interactions
11/17/2011	US20110281285 Assay for Detecting Cathepsin K Activty in Bone, Cartilage and/or Soft Tissue
11/17/2011	US20110281284 Novel liver cancer marker
11/17/2011	US20110281283 Yeast cell wall components and detection thereof
11/17/2011	US20110281282 Subpopulations of spore-like cells and uses thereof
11/17/2011	US20110281281 Integration-free human induced pluripotent stem cells from blood
11/17/2011	US20110281280 Methods and Compositions for Monitoring and Risk Prediction in Cardiorenal Syndrome
11/17/2011	US20110281279 CIRCULATING Epha2 RECEPTOR
11/17/2011	US20110281277 Composition, kit, and method for diagnosing colorectal cancer or ovarian cancer
11/17/2011	US20110281274 Cosmetic use of an active agent capable of stimulating tensin 1 expression
11/17/2011	US20110281263 Compositions and Methods for Detection of Chromosomal Aberrations with Novel Hybridization Buffers
11/17/2011	US20110281258 Human Immunodeficiency Virus And Uses Thereof
11/17/2011	US20110280913 Methods and Compositions for Delivering Therapeutic Agents in the Treatment of B-Cell Related Disorders
11/17/2011	US20110280910 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis
11/17/2011	US20110280901 Diagnosis and treatment of Trypanosoma cruzi infection and chagas disease
11/17/2011	US20110280900 Clostridium chauvoei polypeptide, dna encoding the polypeptide and a vaccine comprising the polypeptide
11/17/2011	US20110280887 Methods for diagnosis of cardiovascular disease
11/17/2011	US20110280886 Treating cancer by modulating mnk
11/17/2011	US20110280883 Fully human anti-epidermal growth factor receptor antibodies
11/17/2011	US20110280880 Prevention, treatment and diagnosis of p.gingivalis infection
11/17/2011	US20110280875 Antibodies which bind human cxcr3
11/17/2011	US20110280870 Hepatocyte growth factor receptor antagonists and uses thereof
11/17/2011	US20110280865 Ets-2 Biomarkers for Fibrotic Diseases and Uses Thereof
11/17/2011	US20110280863 Methods and compositions for the detection and treatment of preeclampsia
11/17/2011	US20110280859 Preventing and treating sepsis
11/17/2011	US20110280808 Novel Compounds for the Treatment of Diseases Associated with Amyloid or Amyloid-Like Proteins
11/17/2011	US20110280766 Efficient sensor for detecting and determining the concentrations of targets
11/17/2011	US20110280467 Method for imaging and differential analysis of cells
11/17/2011	US20110278180 Analyte Determination Method and Analyte Meter
11/17/2011	US20110278179 DNA analysis method and DNA analyzer
11/17/2011	US20110277903 Method and apparatus for reducing heat release and smoke density
11/17/2011	US20110277683 Microstamping Activated Polymer Surfaces
11/17/2011	US20110277568 Ni-Ti SEMI-FINISHED PRODUCTS AND RELATED METHODS
11/17/2011	US20110277538 Volatile Organic Compounds as Diagnostic Markers in the Breath for Lung Cancer
11/17/2011	US20110277537 Alcohol drinking state check device
11/17/2011	US20110277536 Method and system for determining levels of gases
11/17/2011	DE10393660B4 Verfahren zur Identifizierung von Protein-CAMs (konstitutiv aktive Mutanten) A method of identifying protein CAMs (constitutively active mutants)
11/17/2011	DE102010029007A1 Vorrichtung zur Bestimmung einer Zusammensetzung eines Kraftstoffgemischs An apparatus for determining a composition of a fuel mixture
11/17/2011	DE102010023099B3 Verfahren und Vorrichtung zum Charakterisieren von biologischen Objekten Method and device for characterization of biological objects
11/17/2011	DE102010020757A1 Verfahren zur Ermittlung einer Viskositäts-Kenngröße eines Motoröls sowie Steuereinrichtung zur elektronischen Motorsteuerung Method for determining a viscosity parameter of an engine oil as well as control means for the electronic engine control
11/17/2011	DE102010020755A1 Verfahren sowie Steuereinrichtung zur Ermittlung einer Viskositäts-Kenngröße eines Motoröls Procedures, and control means for determining a characteristic viscosity of the engine oil
11/17/2011	DE102010020754A1 Verfahren sowie Steuereinrichtung zur Ermittlung einer Viskositäts-Kenngröße eines Öls Procedures, and control means for determining a characteristic viscosity of an oil
11/17/2011	DE102010020182A1 Device for objective evaluation of handhold, stiffness or similar physical characteristics of planar formations and synthetic materials, has pipes or batons firmly or freely rotary attached at bend of sample
11/17/2011	DE102010007243B4 Therapieoptimierung bei Krebspatienten durch Austesten von Therapiekombinationen mittels in vitro Testungen (Zusatz) Optimizing therapy for cancer patients by testing combinations of therapy by in vitro tests (additional)
11/17/2011	CA2835489A1 Zanamivir phosphonate congeners with anti-influenza activity and determining oseltamivir susceptibility of influenza viruses
11/17/2011	CA2834108A1 Screening assays based on mag and/or abhd6 for selecting insulin secretion promoting agents
11/17/2011	CA2799420A1 Compositions and methods for treating neoplasia, inflammatory disease and other disorders
11/17/2011	CA2799403A1 Compositions and methods for treating leukemia
11/17/2011	CA2799359A1 Method for the diagnosis/prognosis of colorectal cancer
11/17/2011	CA2799309A1 Diagnostic autoantibody profiles for the detection and diagnosis of neurodegenerative diseases
11/17/2011	CA2799220A1 Vessel outgassing inspection methods
11/17/2011	CA2799197A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases
11/17/2011	CA2799169A1 Chlorotoxin variants, conjugates, and methods for their use
11/17/2011	CA2799165A1 Diagnostic markers for neuropsychiatric disease
11/17/2011	CA2799159A1 A luminescence based sensor
11/17/2011	CA2799137A1 System for measuring or monitoring the quality of a liquid medium with low energy consumption
11/17/2011	CA2798920A1 Detection of nicotine metabolites
11/17/2011	CA2798713A1 Markers for acute kidney injury
11/17/2011	CA2798434A1 Discrete states for use as biomarkers
11/17/2011	CA2798328A1 Yeast cell wall components and detection thereof
11/17/2011	CA2797720A1 Humanized and chimeric monoclonal antibodies to cd47
11/17/2011	CA2796171A1 Method and means for identifying substances which inhibit ige production
11/17/2011	CA2795575A1 Methods for the diagnosis, control and prophylaxis of inflammation and mitigation of inflammatory conditions in canines
11/17/2011	CA2795438A1 Method of detecting and profiling progression of the risk of neurodegenerative diseases
11/16/2011	EP2386864A1 Diagnosis and monitoring of Ischemia
11/16/2011	EP2386863A1 Diagnosis and monitoring of multiple organ failure
11/16/2011	EP2386862A1 Methods and kits for diagnosing appendicitis
11/16/2011	EP2386861A2 Cross-ß structure binding compounds

1 ... 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 ... 3937